Owc Pharmaceutical Research Stock Buy Hold or Sell Recommendation
| OWCP Stock | USD 0.0001 0.00 0.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding OWC Pharmaceutical Research is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell OWC Pharmaceutical Research given historical horizon and risk tolerance towards OWC Pharmaceutical. When Macroaxis issues a 'buy' or 'sell' recommendation for OWC Pharmaceutical Research, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out OWC Pharmaceutical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as OWC and provide practical buy, sell, or hold advice based on investors' constraints. OWC Pharmaceutical Research. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
OWC |
Execute OWC Pharmaceutical Buy or Sell Advice
The OWC recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on OWC Pharmaceutical Research. Macroaxis does not own or have any residual interests in OWC Pharmaceutical Research or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute OWC Pharmaceutical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
OWC Pharmaceutical Trading Alerts and Improvement Suggestions
| OWC Pharmaceutical is way too risky over 90 days horizon | |
| OWC Pharmaceutical has some characteristics of a very speculative penny stock | |
| OWC Pharmaceutical appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (10.26 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| OWC Pharmaceutical Research currently holds about 1.47 M in cash with (2.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
OWC Pharmaceutical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to OWC Pharmaceutical or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that OWC Pharmaceutical's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a OWC pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 337.33 | |
Ir | Information ratio | 0.00 |
OWC Pharmaceutical Volatility Alert
At this time OWC Pharmaceutical Research exhibits very low volatility. OWC Pharmaceutical Research appears to be a penny stock. Although OWC Pharmaceutical Research may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in OWC Pharmaceutical Research or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on OWC instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.OWC Pharmaceutical Fundamentals Vs Peers
Comparing OWC Pharmaceutical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze OWC Pharmaceutical's direct or indirect competition across all of the common fundamentals between OWC Pharmaceutical and the related equities. This way, we can detect undervalued stocks with similar characteristics as OWC Pharmaceutical or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of OWC Pharmaceutical's fundamental indicators could also be used in its relative valuation, which is a method of valuing OWC Pharmaceutical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare OWC Pharmaceutical to competition |
| Fundamentals | OWC Pharmaceutical | Peer Average |
| Return On Asset | -0.64 | -0.14 |
| Current Valuation | 49.75 K | 16.62 B |
| Shares Outstanding | 497.5 M | 571.82 M |
| Shares Owned By Insiders | 11.15 % | 10.09 % |
| Price To Earning | (12.76) X | 28.72 X |
| Price To Book | 42.29 X | 9.51 X |
| EBITDA | (10.25 M) | 3.9 B |
| Net Income | (10.26 M) | 570.98 M |
| Cash And Equivalents | 1.47 M | 2.7 B |
| Cash Per Share | 0.01 X | 5.01 X |
| Debt To Equity | 0.15 % | 48.70 % |
| Current Ratio | 3.12 X | 2.16 X |
| Book Value Per Share | (0.02) X | 1.93 K |
| Cash Flow From Operations | (2.5 M) | 971.22 M |
| Earnings Per Share | (0.01) X | 3.12 X |
| Number Of Employees | 9 | 18.84 K |
| Beta | -224.47 | -0.15 |
| Market Capitalization | 49.75 K | 19.03 B |
| Total Asset | 3.55 M | 29.47 B |
| Retained Earnings | (25.14 M) | 9.33 B |
| Working Capital | (75 K) | 1.48 B |
| Current Asset | 112 K | 9.34 B |
| Current Liabilities | 187 K | 7.9 B |
| Z Score | -16.4 | 8.72 |
| Net Asset | 3.55 M |
OWC Pharmaceutical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as OWC . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 | |||
| Relative Strength Index | 60.02 |
About OWC Pharmaceutical Buy or Sell Advice
When is the right time to buy or sell OWC Pharmaceutical Research? Buying financial instruments such as OWC Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having OWC Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Crypto And Gold Thematic Idea Now
Crypto And Gold
Assets that cancel away each other volatility by providing diversification into gold investment combined with digital assets. The Crypto And Gold theme has 54 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Crypto And Gold Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for OWC Pink Sheet Analysis
When running OWC Pharmaceutical's price analysis, check to measure OWC Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OWC Pharmaceutical is operating at the current time. Most of OWC Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of OWC Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OWC Pharmaceutical's price. Additionally, you may evaluate how the addition of OWC Pharmaceutical to your portfolios can decrease your overall portfolio volatility.